. . . . . . . . . "Spironolactone, USP is contraindicated for patients with anuria, acute renal insufficiency, significant impairment of renal excretory function, hyperkalemia, Addison's disease or other conditions associated with hyperkalemia, and with concomitant use of eplerenone." . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "auEurIPrGr9yXEpJMCMRLd0lRDJU8yFGjX/G2fcCpmsdMJKPz+cuu9dKdQJjOEI6dvxnQ6kbzjZHTb53a9g66f/wVfxHY5IVMo2V5mqYm6TIiH4jdvJgsOU1dYI3v0E3PL+YXtKtZb4oKoWXLOBCpXTYHDuNQaE314xk52E7NDA=" . . "2021-08-16T14:59:28.763+02:00"^^ . . . . .